Researchers are excited about the medication , a innovative dual agonist showing significant outcomes in initial trials for body loss . It functions by targeting both systems: GLP-1 and GIP, these, when stimulated, help regulate hunger and enhance energy expenditure . Early findings demonstrate considerable weight reduction and likely improvements